Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HIV & AIDS Health Center

Font Size

New Class of AIDS Drugs on the Horizon

WebMD Health News

Jan. 27, 2000 (Atlanta) -- Discovery of the second member of a new class of HIV drugs promises to greatly expand AIDS treatment options -- someday. Merck researchers report in the journal Science that they have identified a class of compounds that specifically attack integrase, an enzyme crucial for HIV to reproduce in the body.

Current AIDS drugs also attack key HIV enzymes at various stages of viral reproduction. Protease inhibitors attack the enzyme needed to break HIV building blocks into correct sizes; reverse transcriptase inhibitors prevent the virus from turning its RNA into the DNA needed to take over cells. Now integrase inhibitors promise to prevent HIV from snipping open human DNA and inserting its own genetic code. A combination of the three types of drugs theoretically would increase the potency of AIDS drug cocktails.

HIV becomes resistant to any single drug. A combination of drugs, the so-called AIDS cocktails, combats this problem. However, the virus eventually becomes resistant to these as well. The hope is that by adding this new type of drug, the cocktails will become vastly more effective.

The first integrase inhibitor was reported on at the 1996 international AIDS conference by W. Edward Robinson, MD, PhD, of the University of California, Irvine. These compounds were first isolated from plants of the Kallawaya people of Bolivia.

"We are encouraged ... but it is in the very, very early stages of development," Merck spokesperson Laurence Hirsch, MD, tells WebMD. "We are a long way from having a new treatment for AIDS."

The findings, nevertheless, are stirring a great deal of interest. The search has been stymied by the lack of a test that can identify true integrase inhibitors. But now Merck researchers Daria J. Hazuda, PhD, and colleagues report that they have developed just such a test -- and that screening of more than 250,000 compounds led to the discovery of the new class of drugs.

"I think it sounds very promising," retroviral integrase expert Samson Chow, PhD, tells WebMD in an interview to provide objective comment. "These compounds are active specifically against integrase and can block HIV replication. You have a whole new class of inhibitors now. Also, it is very important that viruses with resistance mutations to protease and reverse transcriptase inhibitors are sensitive to integrase. This opens up the possibility of a whole new combination treatment regimen."

Today on WebMD

How much do you know?
contemplative man
What to do now.
Should you be tested?
HIV under microscope
What does it mean?
HIV AIDS Screening
man opening condom wrapper
HIV AIDS Treatment
Discrimination Stigma
Treatment Side Effects
grilled chicken and vegetables
obese man standing on scale
cold sore